Rivaroxaban in acute venous thromboembolism: UK prescribing experience
Abstract Background Rivaroxaban was reported as effective as traditional therapies for the acute treatment of venous thromboembolism (VTE) with fewer major bleeding complications in the seminal Einstein program and is now a recommended option for the treatment of VTE around the world. Objective To r...
Saved in:
| Main Authors: | Victoria Speed, Jignesh P. Patel, Derek Cooper, Stephen Miller, Lara N. Roberts, Raj K. Patel, Roopen Arya |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Wiley
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/db335699e1044ab696bb5ca000565e53 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review
by: Qiyan Cai, et al.
Published: (2021) -
Profilaxis de enfermedad tromboembólica en pacientes hospitalizados con patología médica, estrechando la brecha entre las guías y la práctica clínica
by: Aizman,Andrés, et al.
Published: (2011) -
Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)
by: Ikuo Fukuda, et al.
Published: (2021) -
PICO Questions and DELPHI Methodology for the Management of Venous Thromboembolism Associated with COVID-19
by: Antoni Riera-Mestre, et al.
Published: (2021) -
Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER
by: Gary E. Raskob, et al.
Published: (2021)